Just a few quick questions before you get started...
|Q4||Approximately 1 in ___ patients with diabetes achieves glycemic, blood pressure, and lipid goals.|
|Q5||2-hour postprandial glucose ≥200 mg/dL is associated with an increased risk of|
|Q6||Which is true regarding the short-acting (exenatide BID) and long-acting (albiglutide, dulaglutide, exenatide QW, liraglutide) GLP-1 receptor agonists?|
|Q7||How did you hear about this webinar?|
|Please click SUBMIT below to proceed to the webinar and earn your CME credit! On the next page, start clicking the right arrow buutton to move through the webinar.|| |